Our Press Releases | Association for Accessible Medicines

New White Paper - Read AAM Report on Drug Shortages

Drug Shortages in the US 2023 A Closer Look at Volume and Price Dynamics

Nov 15, 2023 | Brian Hart

AAM Statement on IQVIA Institute Report Examining Drug Shortages

2023 The U.S. Generic & Biosimilar Medicines Savings Report

Sep 6, 2023 | Monét Stanford

Generic and Biosimilar Drugs Generate $408 Billion in Savings For America’s Patients and Health-Care System in 2022

Image of MN State House

Jul 5, 2023 | Susan Reilly

AAM Requests Federal Injunction to Block Minnesota’s Unconstitutional Drug Price Law

supreme court

May 15, 2023 | Susan Reilly

AAM Statement on U.S. Supreme Court Decision to Decline Hearing GSK v. Teva

May 11, 2023 | Susan Reilly

4GRxANTED Campaign Generates Millions of Doses of Generic Medicine for Patients in Need

white house side view

Mar 7, 2023 | Susan Reilly

AAM Statement on President Biden's Budget Plan

Feb 21, 2023 | Susan Reilly

AAM Announces 2023 Associate Members

Feb 16, 2023 | Susan Reilly

AAM Announces 2023 Board of Directors

HHS building

Feb 15, 2023 | Susan Reilly

AAM Statement on CMMI Report

Feb 15, 2023 | Susan Reilly

New Social Media Campaign Unveiled to Raise Awareness of the Essential Role of Generic Medicine in Americans’ Lives

Feb 13, 2023 | Susan Reilly

Christine Baeder Named Chair of the Association for Accessible Medicines Board of Directors

Jan 30, 2023 | Susan Reilly

AAM Applauds CMS for Requiring Health Plans to Place Generic Drugs On Generic Tiers